![](https://stocktraders.online/wp-content/uploads/2024/12/wp-header-logo-676.png)
Last month, investors were overwhelmed with data releases. Between Election Day, earnings season, and monthly economic reports, it would have been easy for something important to fly under the radar.
For instance, investors may have overlooked that Nov. 14 was the deadline for institutional investors with at least $100 million in assets under management to file Form 13F with the Securities and Exchange Commission. A 13F provides a clear snapshot for investors that allows them to see which stocks Wall Street’s most-prominent money managers have been buying and selling.
Start Your Mornings Smarter! Wake up with Breakfast news in your inbox every market day. Sign Up For Free »
Historically, Warren Buffett’s Berkshire Hathaway provides the most-anticipated of all 13Fs. But the “Oracle of Omaha” isn’t the only billionaire known to garner attention on Wall Street.
Take Millennium Management’s billionaire chief Israel Englander as a perfect example. Englander oversees thousands of positions, which includes put and call options, for his fund.
While there have been countless trades made by Englander and his team since 2024 began, buying and selling activity in two of Wall Street’s buzziest stocks have raised some eyebrows.
When most investors think of artificial intelligence (AI) and the multitrillion addressable market attached to AI, hardware kingpin Nvidia probably comes to mind. But there’s another hypergrowth AI stock that Englander has been busy selling over the previous three quarters.
Based on Millennium Management’s last three 13Fs, Englander has overseen the sale of 11,085,606 shares of cloud-based data-mining specialist Palantir Technologies (NASDAQ: PLTR), which has reduced his fund’s stake in the company by 96%! It should be noted that Millennium also holds put and call options in Palantir, so there’s a potential hedge in place.
Over the trailing two years, shares of Palantir have skyrocketed by almost 745%. In other words, simple profit-taking is a viable catalyst that might have Millennium’s brightest investment minds ringing the register. Then again, there may be more behind this selling than meets the eye.
The most-glaring flaw with Palantir Technologies is the company’s otherworldly valuation. As of the closing bell on Dec. 2, shares of the company were valued at close to 44 times consensus sales for 2025, as well as a multiple of 141 times projected earnings per share (EPS) for the upcoming year. A forward-year price-to-sales multiple of 44 is indicative of a bubble.